Astal Laboratories Stock: price and insider trades · India
1 insider bought €18k of shares over the last 90 days, the latest by ACESO RESEARCH LABS LLP, filed 11 Sept 2026.
Astal Laboratories: what insiders have been doing
Astal Laboratories has a thin disclosure history in our data (latest filing: 11 September 2026). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -12.0%Entry ₹74.97 · Close at T+30 ₹66.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 25,417 shares@ ₹78.70100.0% of flowEquityMarket PurchaseSEBI:41b26d46f191e367f54e333ea7f65c90694baa99Canonical exit: 10 Dec 2026 (T+90)
1 of 1 declaration
About Astal Laboratories
Astal Laboratories is a company focused on developing pharmaceutical solutions. It operates in the XBOM market.